Logo image of SHCR

SHARECARE INC (SHCR) Stock Fundamental Analysis

NASDAQ:SHCR - Nasdaq - US81948W1045 - Common Stock - Currency: USD

1.43  -0.01 (-0.35%)

After market: 1.43 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SHCR. SHCR was compared to 37 industry peers in the Health Care Technology industry. While SHCR seems to be doing ok healthwise, there are quite some concerns on its profitability. SHCR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SHCR had negative earnings in the past year.
SHCR had a negative operating cash flow in the past year.
SHCR had negative earnings in each of the past 5 years.
In multiple years SHCR reported negative operating cash flow during the last 5 years.
SHCR Yearly Net Income VS EBIT VS OCF VS FCFSHCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

SHCR has a Return On Assets of -24.25%. This is comparable to the rest of the industry: SHCR outperforms 54.05% of its industry peers.
The Return On Equity of SHCR (-31.01%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -24.25%
ROE -31.01%
ROIC N/A
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SHCR Yearly ROA, ROE, ROICSHCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 100 200 300

1.3 Margins

SHCR has a worse Gross Margin (44.04%) than 67.57% of its industry peers.
SHCR's Gross Margin has declined in the last couple of years.
SHCR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
SHCR Yearly Profit, Operating, Gross MarginsSHCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

6

2. Health

2.1 Basic Checks

SHCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SHCR has been reduced compared to 1 year ago.
SHCR has a worse debt/assets ratio than last year.
SHCR Yearly Shares OutstandingSHCR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 100M 200M 300M
SHCR Yearly Total Debt VS Total AssetsSHCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.73, we must say that SHCR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.73, SHCR perfoms like the industry average, outperforming 48.65% of the companies in the same industry.
There is no outstanding debt for SHCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.73
ROIC/WACCN/A
WACC9.12%
SHCR Yearly LT Debt VS Equity VS FCFSHCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.02 indicates that SHCR has no problem at all paying its short term obligations.
SHCR has a Current ratio (2.02) which is comparable to the rest of the industry.
SHCR has a Quick Ratio of 2.02. This indicates that SHCR is financially healthy and has no problem in meeting its short term obligations.
SHCR's Quick ratio of 2.02 is in line compared to the rest of the industry. SHCR outperforms 59.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 2.02
SHCR Yearly Current Assets VS Current LiabilitesSHCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

SHCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.43%.
SHCR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.11%.
The Revenue has been growing by 10.63% on average over the past years. This is quite good.
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%

3.2 Future

Based on estimates for the next years, SHCR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.33% on average per year.
Based on estimates for the next years, SHCR will show a small growth in Revenue. The Revenue will grow by 0.95% on average per year.
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SHCR Yearly Revenue VS EstimatesSHCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
SHCR Yearly EPS VS EstimatesSHCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SHCR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SHCR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHCR Price Earnings VS Forward Price EarningsSHCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHCR Per share dataSHCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.49%
EPS Next 3Y11.33%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SHCR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SHARECARE INC

NASDAQ:SHCR (10/21/2024, 8:00:02 PM)

After market: 1.43 0 (0%)

1.43

-0.01 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-09 2024-08-09/bmo
Earnings (Next)11-07 2024-11-07/bmo
Inst Owners38.79%
Inst Owner Change0%
Ins Owners0.1%
Ins Owner Change-14540.9%
Market Cap531.79M
Analysts48.89
Price Target1.46 (2.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.56%
Min EPS beat(2)-68.07%
Max EPS beat(2)-47.05%
EPS beat(4)1
Avg EPS beat(4)-39.36%
Min EPS beat(4)-68.07%
Max EPS beat(4)8.5%
EPS beat(8)1
Avg EPS beat(8)-38.89%
EPS beat(12)2
Avg EPS beat(12)-55.49%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.26%
Min Revenue beat(2)-12.09%
Max Revenue beat(2)-2.43%
Revenue beat(4)0
Avg Revenue beat(4)-6.75%
Min Revenue beat(4)-12.09%
Max Revenue beat(4)-2.22%
Revenue beat(8)3
Avg Revenue beat(8)-2.77%
Revenue beat(12)5
Avg Revenue beat(12)-2.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.32
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB 4.32
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS1.09
BVpS1.18
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.25%
ROE -31.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.04%
FCFM N/A
ROA(3y)-16.38%
ROA(5y)N/A
ROE(3y)-20.16%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.69%
GM growth 5YN/A
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.08%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 2.02
Altman-Z 0.73
F-Score5
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)6.08%
Cap/Depr(5y)6.54%
Cap/Sales(3y)0.6%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y4.89%
EPS Next 2Y14.49%
EPS Next 3Y11.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.11%
Revenue growth 3Y10.63%
Revenue growth 5YN/A
Sales Q2Q%-14.58%
Revenue Next Year-13.1%
Revenue Next 2Y-2.87%
Revenue Next 3Y0.95%
Revenue Next 5YN/A
EBIT growth 1Y-15.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.69%
EBIT Next 3Y30.06%
EBIT Next 5YN/A
FCF growth 1Y82.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.64%
OCF growth 3YN/A
OCF growth 5YN/A